Cargando…
Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment
Metabolomics studies in sickle cell disease (SCD) have been so far limited to tens of samples, owing to technical and experimental limitations. To overcome these limitations, we performed plasma metabolomics analyses on 596 samples from patients with SCD enrolled in the WALK-PHaSST study (clinicaltr...
Autores principales: | D’Alessandro, Angelo, Nouraie, S. Mehdi, Zhang, Yingze, Cendali, Francesca, Gamboni, Fabia, Reisz, Julie A., Zhang, Xu, Bartsch, Kyle W., Galbraith, Matthew D., Espinosa, Joaquin M., Gordeuk, Victor R., Gladwin, Mark T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690926/ https://www.ncbi.nlm.nih.gov/pubmed/37439373 http://dx.doi.org/10.3324/haematol.2023.283288 |
Ejemplares similares
-
Variation and impact of polygenic hematologic traits in monogenic sickle cell disease
por: Pincez, Thomas, et al.
Publicado: (2022) -
Increased retention of functional mitochondria in mature sickle red blood cells is associated with increased sickling tendency, hemolysis and oxidative stress
por: Esperti, Sofia, et al.
Publicado: (2023) -
Assessment of functional shunting in patients with sickle cell disease
por: Afzali-Hashemi, Liza, et al.
Publicado: (2022) -
Ionophore-mediated swelling of erythrocytes as a therapeutic mechanism in sickle cell disease
por: Geisness1, Athena C., et al.
Publicado: (2021) -
Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease
por: Khasabova, Iryna A., et al.
Publicado: (2022)